Acute Effect of Tai Chi Versus Moderate-Intensity Combined Exercise on Cardiovascular, Metabolic, and Cardiac Autonomic Control Parameters in Older Men and Women With Type 2 Diabetes Mellitus
The Acute Effect of Tai Chi Versus Moderate-Intensity Combined Exercise on Cardiovascular, Metabolic, and Cardiac Autonomic Control Parameters in Older Men and Women With Type 2 Diabetes Mellitus: A Randomized, Single-Blind, Crossover Controlled Trial
1 other identifier
interventional
24
0 countries
N/A
Brief Summary
Type 2 diabetes mellitus (T2DM) in the elderly population is associated with compromised cardiovascular and metabolic functions, thereby necessitating the implementation of safe exercise interventions. This study employs a randomized, single-blind, crossover design will be conducted in Brazil to examine whether Tai Chi, a low-impact mind-body exercise, offers acute benefits comparable to those of moderate-intensity combined exercise (MICE) in 24 older adults (≥65 years) diagnosed with T2DM, consisting of 12 men and 12 women. Participants recruited through community advertisements and screened to ensure inactivity, stable medication usage, and the absence of significant comorbidities will undergo randomized sessions of Tai Chi, MICE, and a control (CON) intervention. Evaluations will include capillary blood glucose (the primary outcome), blood pressure, heart rate variability, arterial stiffness (PWVcf), and endothelial function (FMD) measured before, immediately after, and 45minute post-intervention, along with 24-hour ambulatory monitoring. Standardized protocols will be employed to regulate physical activity. By juxtaposing these interventions, the study seeks to ascertain if Tai Chi could serve as a feasible alternative for enhancing acute metabolic and cardiovascular responses in older diabetic adults, thus providing practical insights for clinical and lifestyle management.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable type-2-diabetes
Started Aug 2025
Shorter than P25 for not_applicable type-2-diabetes
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 22, 2025
CompletedFirst Posted
Study publicly available on registry
August 8, 2025
CompletedStudy Start
First participant enrolled
August 20, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 20, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
November 20, 2025
CompletedAugust 8, 2025
August 1, 2025
2 months
July 22, 2025
August 7, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Capillary blood glucose change from baseline
Capillary blood glucose will be measured using a digital glucometer (FreeStyle Optium Neo, 163 Abbott, Oxon, UK) in milligrams per deciliter (mg/dL)
Baseline (minute 0), immediately after the intervention (minute 60) and 45 minutes after the intervention (minute 105)
Secondary Outcomes (7)
Carotid-femoral pulse wave velocity (PWVcf) change from baseline
Baseline (minute 0), immediately after the intervention (minute 60) and 45 minutes after the intervention (minute 105)
Brachial artery flow-mediated dilation (FMD) change from baseline
Baseline (minute 0), immediately after the intervention (minute 60) and 45 minutes after the intervention (minute 105)
Central blood pressures change from baseline
Baseline (minute 0), immediately after the intervention (minute 60) and 45 minutes after the intervention (minute 105)
Heart rate variability (HRV) change from baseline
Baseline (minute 0), immediately after the intervention (minute 60) and 45 minutes after the intervention (minute 105)
Brachial blood pressure (BP) change from baseline
Baseline (minute 0), immediately after the intervention (minute 60) and 45 minutes after the intervention (minute 105)
- +2 more secondary outcomes
Other Outcomes (2)
Augmentation Index (AIx) change from baseline
Baseline (minute 0), immediately after the intervention (minute 60) and 45 minutes after the intervention (minute 105)
Heart rate change from baseline
Baseline (minute 0), immediately after the intervention (minute 60) and 45 minutes after the intervention (minute 105)
Study Arms (3)
Tai Chi
EXPERIMENTAL40-60 minute supervised Yang-style Tai Chi lesson (24-form simplified pattern). Focus on calm, controlled movements and breathing coordination.
Moderate-Intensity Exercise (MICE)
EXPERIMENTALThe MICE session will consist of five minutes of warm-up (joint mobility and stretching exercises between PSE levels 9 and 11, 30 minutes of walking on the treadmill between PSE levels 12 and 13, 20 minutes of muscle strengthening exercises between levels 12 and 14 of PSE (two sets of 15 to 20 repetitions in circuit in the exercises bent row with elastic band, bodyweight squats, adapted push-ups (on the wall or on the counter), deadlifts with an elastic band, presses with an elastic band and an abdominal band on the floor or adapted on the chair) and five minutes of back to calm (light stretching and breathing exercises at PSE level 9).
Control (No Exercise)
SHAM COMPARATORThe CON session will consist of 60 minutes of rest in the sitting position. Participants will be told not to sleep and will not have access to reading or electronic devices during the CON session.
Interventions
start from warm up (5 minute )repetitions in circuit in the exercises bent row with elastic band, bodyweight squats, adapted push-ups (on the wall or on the counter), deadlifts with an elastic band, presses with an elastic band and an abdominal band on the floor or adapted on the chair and cool down in the end
The CON session will last 60 minutes and will be conducted only sitting. Participants will be told not to sleep and will not be allowed to use reading materials or any electrical gadgets during the CON session.
Eligibility Criteria
You may qualify if:
- only with type 2 diabetes
You may not qualify if:
- if not able to perform physical exercise (Extreme neuropathy, wounds in the feet, and amputation risk.)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Full Professor of Department of Physical Education
Study Record Dates
First Submitted
July 22, 2025
First Posted
August 8, 2025
Study Start
August 20, 2025
Primary Completion
October 20, 2025
Study Completion
November 20, 2025
Last Updated
August 8, 2025
Record last verified: 2025-08
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF, CSR, ANALYTIC CODE
- Time Frame
- Initial data will be analysed after completing all 3 interventions .
- Access Criteria
- Informed Consent Form described and signed. DP will received Informed Consent Form informing the objectives, study deling, interventions, analyses, risks and benefits. Participation in this study will be voluntary and confidential after signing of an informed consent.
Participants who are interested in participating will provide an anamnesis to the investigator. The investigator will evaluate the IDP eligibility or non-eligibility criteria. Each qualified participant will get a document that includes the research protocol, statistical analysis plan, informed consent form, clinical study report, and analytic code information. Thus, scientists will do cardiopulmonary activity tests to assess if IDP will be able to study the program.